Changes in beliefs identify unblinding in randomized controlled trials: A method to meet CONSORT guidelines

Contemporary Clinical Trials

Volumn 26, Issue 1, 2005, Pages 25-37

  Rees, Judy R ^a,f   Wade, Timothy J ^b   Levy, Deborah A ^c   Colford Jr , John M ^d   Hilton, Joan F ^e  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Double blind method; Masking; Placebo effect; Randomized controlled trial; Research design

Indexed keywords

PLACEBO; WATER;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; METHODOLOGY; NORMAL HUMAN; PRACTICE GUIDELINE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WATER TREATMENT; CROSS-SECTIONAL STUDY; DOUBLE BLIND PROCEDURE; INSTRUMENTATION; LONGITUDINAL STUDY; SENSITIVITY AND SPECIFICITY; UNITED STATES; WATER MANAGEMENT;

CALIFORNIA; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; HUMANS; LONGITUDINAL STUDIES; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; WATER PURIFICATION;

EID: 17844373818     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2004.11.020     Document Type: Article

References (33)

1. C. Begg, M. Cho, S. Eastwood, R. Horton, D. Moher, and I. Olkin Improving the quality of reporting of randomized controlled trials. The CONSORT statement JAMA 276 1996 637 639
2. D.G. Altman, K.F. Schulz, D. Moher, M. Egger, F. Davidoff, and D. Elbourne The revised CONSORT statement for reporting randomized trials: explanation and elaboration Ann. Intern. Med. 134 2001 663 694
3. D. Fergusson, K.C. Glass, D. Waring, and S. Shapiro Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials BMJ 328 2004 432
4. K.F. Schulz, I. Chalmers, and D.G. Altman The landscape and lexicon of blinding in randomized trials Ann. Intern. Med. 136 2002 254 259
5. H. Kiene A critique of the double-blind clinical trial. Part 1 Altern. Ther. Health Med. 2 1996 74 80
6. H. Kiene A critique of the double-blind clinical trial. Part 2 Altern. Ther. Health Med. 2 1996 59 64
7. K.M. Mattocks, and R.I. Horwitz Placebos, active control groups, and the unpredictability paradox Biol. Psychiatry 47 2000 693 698
8. H.-C. Diener, A.J. Dowson, M. Ferrari, G. Nappi, and P. Tfelt-Hansen Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials Cephalalgia 19 1999 699 700
9. R.I. Horwitz, and S.M. Horwitz Adherence to treatment and health outcomes Arch. Int. Med. 153 1993 1863 1868
10. K. McPherson, A.R. Britton, and J.E. Wennberg Are randomized controlled trials controlled? Patient preferences and unblind trials J. R. Soc. Med. 90 1997 652 656
11. N.A. Desbiens In randomized controlled trials, should subjects in both placebo and drug groups be expected to guess that they are taking drug 50% of the time? Med. Hypotheses 59 3 2002 227 232
12. P.G. Ney, C. Collins, and C. Spensor Double blind: double talk or are there ways to do better research Med. Hypotheses 21 2 1986 119 126
13. R.P. Byington, J.D. Curb, and M.E. Mattson Assessment of double-blindness at the conclusion of the beta-blocker heart attack trial JAMA 253 1985 1733 1736
14. J. Howard, A.S. Whittemore, J.J. Hoover, and M. Panos How blind was the patient blind in AMIS? Clin. Pharmacol. Ther. 32 1982 543 553
15. T.R. Karlowski, T.C. Chalmers, L.D. Frenkel, A.Z. Kapikian, T.L. Lewis, and J.M. Lynch Ascorbic acid for the common cold. A prophylactic and therapeutic trial JAMA 231 1975 1038 1042
16. P. Juni, G.A. Altman, and M. Egger Assessing the quality of controlled clinical trials BMJ 323 2001 42 46
17. D. Moher, K.F. Schulz, and D.G. Altman The revised CONSORT statement for reporting randomized clinical trials Ann. Intern. Med. 134 2001 657 662
18. J.R. Hughes, and D. Krahn Blindness and the validity of the double-blind procedure J. Clin. Psychopharmacol. 5 1985 138 142
19. K.E. James, D.A. Bloch, K.K. Lee, H.C. Kraemer, and R.K. Fuller An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation-a VA cooperative study Stat. Med. 15 1996 1421 1434
20. J.L. Marini, M.H. Sheard, C.I. Bridges, and E. Wagner An evaluation of the double-blind design in a study comparing lithium carbonate with placebo Acta Psychiatr. Scand. 53 1976 343 354
21. M. Moscucci, L. Byrne, M. Weintraub, and C. Cox Blinding, unblinding, and the placebo effect: an analysis of patients' guesses of treatment assignment in a double-blind clinical trial Clin. Pharmacol. Ther. 41 1987 259 265
22. J.H. Noseworthy, G.C. Ebers, M.K. Vandervoort, R.E. Farquhar, E. Yetisir, and R. Roberts The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial Neurology 44 1994 16 20
23. H. Bang, L. Ni, and C.E. Davis Assessment of blinding in clinical trials Control. Clin. Trials 25 2004 143 156
24. R.A. Deyo, N.E. Walsh, L.S. Schoenfeld, and S. Ramamurthy Can trials of physical treatments be blinded? The example of transcutaneous electrical nerve stimulation for chronic pain Am. J. Phys. Med. Rehab. 69 1990 6 10 [see comments]
25. J.M. Colford, J.R. Rees, T.J. Wade, A. Khalakdina, J. Hilton, and I. Ergas Participant blinding and gastrointestinal illness in a randomized, controlled trial of an in-home drinking water intervention Emerg. Infect. Dis. 8 2002 29 36
26. J.R. Rees A drinking water evaluation trial. School of public health 2001 University of California Berkeley 322
27. P. Payment, L. Richardson, J. Siemiatycki, R. Dewar, M. Edwardes, and E. Franco A randomized trial to evaluate the risk of gastrointestinal disease due to consumption of drinking water meeting current microbiological standards Am. J. Public Health 81 1991 703 708
28. S. Greenland Basic methods for sensitivity analysis of biases Int. J. Epidemiol. 25 1996 1107 1116
29. K.T. Copeland, H. Checkoway, A.J. McMichael, and R.H. Holbrook Bias due to misclassification in the estimation of relative risk Am. J. Epidemiol. 105 1977 405 488
30. O.S. Miettinen, and E.F. Cook Confounding: essence and detection Am. J. Epidemiol. 114 4 1981 593 603
31. C. Weinberg Towards a clearer definition of confounding Am. J. Epidemiol. 137 1993 1 8
32. J. Robins The control of confounding by intermediate variables Stat. Med. 8 1989 679 701
33. J.M. Robins Marginal structural models and causal inference in epidemiology Epidemiology 11 2000 550 560